Unwinding the role of senataxin in neurodegeneration.
Interest in senataxin biology began in 2004 when mutations were first identified in what was then a novel protein. Dominantly inherited mutations were documented in rare juvenile-onset, motor neuron disease pedigrees in a familial form of amyotrophic lateral sclerosis (ALS4), while recessive mutations were found to cause a severe early-onset ataxia with oculomotor apraxia (AOA2) that is actually the second most common recessive ataxia after Freidreich's ataxia. From earlier studies of sen1p, the yeast ortholog of senataxin, a range of important RNA processing functions have been attributed to this protein. Like sen1p, senataxin contains a helicase domain to interact with RNA and an amino-terminal domain for critical protein interactions. Senataxin also joins a group of important proteins responsible for maintaining RNA transcriptome homeostasis, including FUS, TDP-43, and SMN that can all cause familial forms of motor neuron disease (MND). Independent of this association, senataxin is gaining attention for its role in maintaining genomic stability. Senataxin has been shown to resolve R-Loop structures, which form when nascent RNA hybridizes to DNA, displacing the non-transcribed strand. But in cycling cells, senataxin is also found at nuclear foci during the S/G2 cell-cycle phase, and may function at sites of specific collision between components of the replisome and transcription machinery. Which of these important processes is most critical to prevent neurodegeneration remains unknown, but our evolving understanding of these processes will be crucial not only for understanding senataxin's role in neurological disease, but also in a number of fundamentally important cellular functions.
Department of Pediatrics and the Sanford Consortium for Regenerative Medicine, University of California, San Diego, La Jolla, CA 92093, USA and Comparative Genomics Centre, School of Molecular and Cell Biology, James Cook University, Townsville, QLD 4811, Australia.
Craig L
CL
Bennett
Departments of Pediatrics, Cellular and Molecular Medicine, and Neurosciences, Division of Biological Sciences, Institute for Genomic Medicine, and the Sanford Consortium for Regenerative Medicine, University of California, San Diego, La Jolla, CA 92093, USA and Rady Children's Hospital, La Jolla, CA 92123, USA.
Albert R
AR
La Spada
D000818:Animals; D001259:Ataxia / Q000473:pathology; D006801:Humans; D008954:Models, Biological; D009046:Motor Neurons / Q000473:pathology; D009154:Mutation; D009410:Nerve Degeneration / Q000378:metabolism* / Q000473:pathology; D020365:RNA Helicases / Q000235:genetics / Q000378:metabolism*
D020365:RNA Helicases